| Financial Year |
March 31 2023 |
| Monetary Funds |
2,856,949,999.28 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
919,613,342.09 |
| Advances to Suppliers |
262,878,938.67 |
| Other Receivables |
46,635,367.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
13,268,728.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
82,134,528.45 |
| Total Current Assets |
4,391,723,033.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
384,940,082.88 |
| Investment Properties |
-- |
| Fixed Assetes |
20,793,947.36 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,317,941.38 |
| R&D expenses |
-- |
| Goodwill |
852,263,659.90 |
| Long-Term Deferred and Prepaid Expenses |
231,578,641.23 |
| Deferred Income Tax Assets |
11,934,566.65 |
| Other Non-Current Assets |
42,357,209.19 |
| Sub-Total of Non-Current Assets |
1,803,374,782.95 |
| Total Assets |
6,195,097,816.28 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
407,819,213.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
38,781,500.37 |
| Taxes Payable |
59,603,805.72 |
| Interest Payable |
-- |
| Dividend Payable |
52,367,232.96 |
| Other payables |
516,574,773.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,929,866.06 |
| Other Current Liabilities |
333,640.68 |
| Sub-Total of Current Liabilities |
1,224,039,795.36 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,338,767.89 |
| Deferred Income Tax Liabilities |
16,135,108.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
34,245,635.63 |
| Total Liabilities |
1,258,285,430.99 |
| Paid-In Capital(Or Share Stock) |
1,515,197,486.00 |
| Capital Surplus |
777,468,852.76 |
| Surplus Reserve |
315,917,851.71 |
| LESS:Treasury Stock |
140,701,119.84 |
| Undistributed Profits |
2,356,967,813.45 |
| Minority Stockholder's Interest |
149,809,393.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,787,002,991.34 |
| Owner's Equity（Stockholder's Equity） |
4,936,812,385.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,195,097,816.28 |
